Il y a eu 50 transactions d'initiés récentes enregistrées pour Indaptus Therapeutics, Inc. (INDP), dont 39 achats et 2 ventes. Le total des achats d'initiés s'élève à $2.81M et le total des ventes d'initiés à $100.73K.
Les initiés notables ayant une activité récente comprennent Lazar David E., Dai Junyi, Yao Yun. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — INDP
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-23 |
Lazar David E. |
Director |
Vente Informative |
700,000 |
- |
- |
- |
| 2026-03-23 |
Dai Junyi |
Chief Executive Officer |
Inconnu |
- |
- |
- |
11,250,000 |
| 2026-03-23 |
Yao Yun |
10 Percent Owner |
Inconnu |
- |
- |
- |
41,991,000 |
| 2026-03-23 |
Sino Lion Ventures Ltd |
10 Percent Owner |
Inconnu |
- |
- |
- |
38,895,000 |
| 2026-02-26 |
Mcmurdo Matthew Charles |
Director |
Inconnu |
- |
- |
- |
25,000 |
| 2026-02-26 |
Jabbour Jerome D |
Director |
Inconnu |
- |
- |
- |
- |
| 2026-02-26 |
Jabbour Jerome D |
Director |
Attribution de RSU |
25,000 |
$2.06 |
$51.5K |
25,000 |
| 2026-02-11 |
Meckler Jeffrey A |
Co-chief Executive Officer |
Restitution d'Actions |
12,136 |
$8.30 |
$100.73K |
- |
| 2026-01-20 |
Ben-tzvi Avraham |
Director |
Attribution de RSU |
25,000 |
- |
- |
25,100 |
| 2026-01-08 |
Natan David |
Director |
Inconnu |
- |
- |
- |
- |
| 2026-01-07 |
Natan David |
Director |
Attribution de RSU |
25,000 |
$2.69 |
$67.25K |
25,000 |
| 2025-12-23 |
Ben-tzvi Avraham |
Director |
Attribution de RSU |
25,000 |
$1.95 |
$48.75K |
25,000 |
| 2025-12-22 |
Lazar David E. |
Co-chief Executive Officer |
Inconnu |
- |
- |
- |
- |
| 2025-12-22 |
Ben-tzvi Avraham |
Director |
Inconnu |
- |
- |
- |
100 |
| 2025-12-22 |
Meckler Jeffrey A |
10 Percent Owner, Officer: Co-chief Executive Officer |
Attribution de RSU |
216,617 |
$2.03 |
$439.73K |
229,929 |
| 2025-12-22 |
Linscott Walt Addison |
Chief Operating Officer |
Attribution de RSU |
54,421 |
$2.03 |
$110.47K |
54,426 |
| 2025-12-22 |
Sassi Nir |
Chief Financial Officer |
Attribution de RSU |
26,758 |
$2.03 |
$54.32K |
26,758 |
| 2025-12-22 |
Newman Michael James |
CSO and Director |
Attribution de RSU |
52,204 |
$2.03 |
$105.97K |
101,074 |
| 2025-07-27 |
Meckler Jeffrey A |
Chief Executive Officer |
Attribution de RSU |
6,068 |
$8.30 |
$50.38K |
13,312 |
| 2025-06-10 |
Hayes William B |
Director |
Attribution de RSU |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2025-06-10 |
Martell Robert |
Director |
Attribution de RSU |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2025-06-10 |
Maddaluna Anthony J |
Director |
Attribution de RSU |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2025-06-10 |
Pomerantz Roger |
Director |
Attribution de RSU |
30,000 |
$0.33 |
$9.9K |
30,000 |
| 2025-06-10 |
Karah Hila |
Director |
Attribution de RSU |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2025-06-10 |
Gilbert Mark John |
Director |
Attribution de RSU |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2024-11-25 |
Meckler Jeffrey A |
CEO and Director |
Attribution de RSU |
42,553 |
$1.05 |
$44.68K |
42,553 |
| 2024-10-09 |
Meckler Jeffrey A |
CEO and Director |
Attribution de RSU |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-10-09 |
Linscott Walt Addison |
Chief Operating Officer |
Attribution de RSU |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-10-09 |
Waltzman Roger J. |
Chief Medical Officer |
Attribution de RSU |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-10-09 |
Sassi Nir |
Chief Financial Officer |
Attribution de RSU |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-10-09 |
Newman Michael James |
10 Percent Owner, Officer: CSO and Director |
Attribution de RSU |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-08-08 |
Meckler Jeffrey A |
CEO and Director |
Attribution de RSU |
84,932 |
$1.70 |
$144.38K |
84,932 |
| 2024-06-06 |
Hayes William B |
Director |
Attribution de RSU |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-06-06 |
Martell Robert |
Director |
Attribution de RSU |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-06-06 |
Maddaluna Anthony J |
Director |
Attribution de RSU |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-06-06 |
Pomerantz Roger |
Director |
Attribution de RSU |
30,000 |
$2.63 |
$78.9K |
30,000 |
| 2024-06-06 |
Karah Hila |
Director |
Attribution de RSU |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-06-06 |
Gilbert Mark John |
Director |
Attribution de RSU |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-01-22 |
Meckler Jeffrey A |
CEO and Director |
Attribution de RSU |
100,000 |
$1.74 |
$174K |
100,000 |
| 2024-01-22 |
Linscott Walt Addison |
Chief Operating Officer |
Attribution de RSU |
75,000 |
$1.74 |
$130.5K |
75,000 |
| 2024-01-22 |
Waltzman Roger J. |
Chief Medical Officer |
Attribution de RSU |
75,000 |
$1.74 |
$130.5K |
75,000 |
| 2024-01-22 |
Sassi Nir |
Chief Financial Officer |
Attribution de RSU |
40,000 |
$1.74 |
$69.6K |
40,000 |
| 2024-01-22 |
Newman Michael James |
10 Percent Owner, Officer: CSO and Director |
Attribution de RSU |
43,250 |
$1.74 |
$75.26K |
43,250 |
| 2023-08-14 |
Anderson Glen R. |
10 Percent Owner |
Achat Informatif |
23,934 |
$2.34 |
$56.01K |
1,190,400 |
| 2023-08-11 |
Anderson Glen R. |
10 Percent Owner |
Achat Informatif |
35,064 |
$2.12 |
$74.34K |
1,166,466 |
| 2023-08-10 |
Anderson Glen R. |
10 Percent Owner |
Achat Informatif |
44,354 |
$1.94 |
$86.05K |
1,131,402 |
| 2023-08-07 |
Waltzman Roger J. |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-08-07 |
Waltzman Roger J. |
Chief Medical Officer |
Attribution de RSU |
90,000 |
$1.85 |
$166.5K |
90,000 |
| 2023-05-25 |
Hayes William B |
Director |
Attribution de RSU |
12,500 |
$1.82 |
$22.75K |
12,500 |
| 2023-05-25 |
Maddaluna Anthony J |
Director |
Attribution de RSU |
12,500 |
$1.82 |
$22.75K |
12,500 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
